Brimonidine Tartrate Ophthalmic Solution, 0.15% has 6 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Alcohol, Barbiturates, Cardiac Glycosides. Patients taking Brimonidine Tartrate Ophthalmic Solution, 0.15% should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Moderate
- 6
Moderate (6)
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Alcohol— CNS depressant; may result in additive or potentiating effect with brimonidine on the central nervous system.
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Barbiturates— CNS depressant; may result in additive or potentiating effect with brimonidine on the central nervous system.
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Cardiac Glycosides— Brimonidine may reduce blood pressure; caution is advised when used with cardiac glycosides due to potential additive hy…
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Monoamine Oxidase Inhibitors (Maois)— May interfere with brimonidine metabolism and potentially result in increased hypotension and systemic side effects; cau…
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Sedatives— CNS depressant; may result in additive or potentiating effect with brimonidine on the central nervous system.
- Brimonidine Tartrate Ophthalmic Solution, 0.15% + Topical Local Anesthetics— CNS depressant; may result in additive or potentiating effect with brimonidine on the central nervous system.